ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) for PFIZER INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to drug pricing, value, and transparency, generally Issues related to biosimilars, generally Rebate reform, patient out-of-pocket costs, and value-based payment arrangements, generally Drug importation Drug shortages Issues related to vaccines, generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Trade (domestic/foreign) TRD
Issues involving international trade, including IP protections
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate tax reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Medicare/Medicaid MMM
Issues related to Medicare Part D, including program restructuring, coverage gap, rebate reform, and out-of-pocket costs Issues related to drug pricing, value, and transparency, generally International Reference Pricing/Most Favored Nations
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.